Literature DB >> 8183468

The influence of obesity and its treatment on the immune system.

D D Stallone1.   

Abstract

Obesity and weight reduction are significant public health concerns in the United States and other developed countries. Although much research has examined the adverse health consequences of overweight and the benefits of weight loss, the effects on immunologic function of either excess adiposity or weight reduction treatments for obesity have received relatively little attention. In general, studies of immunologic function in obese humans and experimental animals indicate that excess adiposity is associated with impairments in host defense mechanisms. Definitive studies of immune function in human obesity are, however, still needed. Preliminary investigations suggest that certain types of weight reduction strategies produce further alterations in immune responsiveness. More research is needed to confirm or refute these initial findings and to assess the long term consequences of weight loss for overweight individuals. Nutritional and neuroendocrine status are among the factors likely to be involved in modulation of immune responses in obesity and as a consequence of dieting and weight reduction.

Entities:  

Mesh:

Year:  1994        PMID: 8183468

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  10 in total

1.  Correlation of Serum and Salivary Cytokines Level With Clinical Parameters in Metabolic Syndrome With Periodontitis.

Authors:  Abhishek Chauhan; Suraj Singh Yadav; Pradeep Dwivedi; Nand Lal; Kauser Usman; Sanjay Khattri
Journal:  J Clin Lab Anal       Date:  2016-02-22       Impact factor: 2.352

2.  Effects of moderate endurance exercise and training on in vitro lymphocyte proliferation, interleukin-2 (IL-2) production, and IL-2 receptor expression.

Authors:  S G Rhind; P N Shek; S Shinkai; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

3.  Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.

Authors:  Yingtai Chen; Tongzhang Zheng; Qing Lan; Francine Foss; Christopher Kim; Xuezhong Chen; Min Dai; Yumin Li; Theodore Holford; Brian Leaderer; Peter Boyle; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

Review 4.  Periodontal innate immune mechanisms relevant to atherosclerosis and obesity.

Authors:  Sami A Zelkha; Robert W Freilich; Salomon Amar
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

5.  The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.

Authors:  M Hillman; C Törn; M Landin-Olsson
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

6.  Effects of a beta3-adrenergic agonist on the immune response in diet-induced (cafeteria) obese animals.

Authors:  O Lamas; J A Martínez; A Marti
Journal:  J Physiol Biochem       Date:  2003-09       Impact factor: 4.158

7.  Evaluation of systemic markers related to anemia of chronic disease in the peripheral blood of smokers and non-smokers with chronic periodontitis.

Authors:  Ebru Olgun Erdemir; Rana Nalcaci; Osman Caglayan
Journal:  Eur J Dent       Date:  2008-04

8.  Paradise -- not without its plagues: overwhelming Blastomycosis pneumonia after visit to lakeside cottages in Northeastern Ontario.

Authors:  Malvinder S Parmar
Journal:  BMC Infect Dis       Date:  2005-05-04       Impact factor: 3.090

9.  Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat.

Authors:  Sammy Bedoui; Elena Velkoska; Steve Bozinovski; Jessica E Jones; Gary P Anderson; Margaret J Morris
Journal:  J Inflamm (Lond)       Date:  2005-03-21       Impact factor: 4.981

10.  Factors influencing severity of community-acquired pneumonia.

Authors:  M Mahendra; B S Jayaraj; Sneha Limaye; S K Chaya; Raja Dhar; P A Mahesh
Journal:  Lung India       Date:  2018 Jul-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.